(19)
(11) EP 3 973 586 A1

(12)

(43) Date of publication:
30.03.2022 Bulletin 2022/13

(21) Application number: 19929933.0

(22) Date of filing: 21.05.2019
(51) International Patent Classification (IPC): 
H01M 10/04(2006.01)
H01M 4/00(2006.01)
 H01M 10/26(2006.01)
(52) Cooperative Patent Classification (CPC):
A61K 31/55; A61K 31/445; A61K 31/27; A61P 25/28; Y02P 70/50
 
C-Sets:
  1. A61K 31/55, A61K 2300/00;
  2. A61K 31/445, A61K 2300/00;
  3. A61K 31/27, A61K 2300/00;
(86) International application number:
PCT/US2019/033359
(87) International publication number:
WO 2020/236159 (26.11.2020 Gazette 2020/48)
(84) Designated Contracting States:
AL AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC MK MT NL NO PL PT RO RS SE SI SK SM TR
Designated Extension States:
BA ME
Designated Validation States:
KH MA MD TN

(71) Applicant: La Pharma Tech Inc.
Blacksburg, VA 24060 (US)

(72) Inventors:
  • WANG, Jianmin
    Blacksburg, VA 24060 (US)
  • CUI, Geping
    Blacksburg, VA 24060 (US)

(74) Representative: Witthoff Jaekel Steinecke Patentanwälte PartG mbB 
Postfach 1140
52412 Jülich
52412 Jülich (DE)

   


(54) NOVEL PHARMACEUTICAL COMPOSITIONS AND METHODS FOR TREATING MENTAL, BEHAVIORAL, COGNITIVE DISORDERS